These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Muscle relaxants and reversal agents. Van Sickel AD; Spadaccia K Crit Care Nurs Clin North Am; 1991 Mar; 3(1):151-8. PubMed ID: 2043325 [TBL] [Abstract][Full Text] [Related]
4. Sugammadex: a novel agent for the reversal of neuromuscular blockade. Nicholson WT; Sprung J; Jankowski CJ Pharmacotherapy; 2007 Aug; 27(8):1181-8. PubMed ID: 17655516 [TBL] [Abstract][Full Text] [Related]
5. The antagonism of nondepolarizing neuromuscular blockade. Jenkins TE AANA J; 1980 Oct; 48(5):452-60. PubMed ID: 6449820 [TBL] [Abstract][Full Text] [Related]
6. [Mechanism of action of muscle relaxants and its clinical problems]. Suzuki H Masui; 1974 Aug; 23(8):679-92. PubMed ID: 4372420 [No Abstract] [Full Text] [Related]
7. Effects of acetylcholinesterase inhibitor therapy for Alzheimer's disease on neuromuscular block. Baruah J; Easby J; Kessell G Br J Anaesth; 2008 Mar; 100(3):420. PubMed ID: 18276655 [No Abstract] [Full Text] [Related]
8. [Cyclodextrin. A new concept for antagonizing muscle relaxants]. Sparr HJ Anaesthesist; 2002 Nov; 51(11):929-30. PubMed ID: 12434269 [No Abstract] [Full Text] [Related]
9. [Blocking of the neuromuscular conduction by decamethylene-bis-pyridinium]. Danilov AF Farmakol Toksikol; 1970; 33(5):536-8. PubMed ID: 4250151 [No Abstract] [Full Text] [Related]
12. Is it always necessary to antagonize residual neuromuscular block? Do children differ from adults? Hunter JM Br J Anaesth; 1996 Dec; 77(6):707-9. PubMed ID: 9014619 [No Abstract] [Full Text] [Related]
13. Delayed reversal of a potentiated rocuronium neuromuscular block. Dubois PE Eur J Anaesthesiol; 2009 Apr; 26(4):350-2. PubMed ID: 19401670 [No Abstract] [Full Text] [Related]
14. Neuromuscular transmission: new concepts and agents. de Boer HD J Crit Care; 2009 Mar; 24(1):36-42. PubMed ID: 19272537 [TBL] [Abstract][Full Text] [Related]
15. [Interaction between various muscle relaxants and our anticurare drugs]. Mitsov V; Vlasovska M Eksp Med Morfol; 1986; 25(2):16-21. PubMed ID: 3017680 [No Abstract] [Full Text] [Related]
16. [Neuromuscular effects of hexafluorene bromide in association with succinylcholine]. Rodríguez Alvarez E Rev Esp Anestesiol Reanim; 1978 Sep; 25(5):426-44. PubMed ID: 155278 [No Abstract] [Full Text] [Related]
17. [Results of the association of depolarizing and non-depolarizing muscle relaxants]. Foldes FF Anesth Analg (Paris); 1971; 28(5):859-69. PubMed ID: 4258297 [No Abstract] [Full Text] [Related]
18. [Sugammadex, a revolutionary new drug to reverse neuromuscular block]. Alvarez Gómez JA Rev Esp Anestesiol Reanim; 2007 Apr; 54(4):205-7. PubMed ID: 17518169 [No Abstract] [Full Text] [Related]
19. Potentiation of muscle relaxants by quinidine. Miller RD; Way WL; Katzung BG Anesthesiology; 1968; 29(5):1069-70. PubMed ID: 4299762 [No Abstract] [Full Text] [Related]
20. Clinical pharmacology of neuromuscular blocking agents. Way WL; Miller RD GP; 1968 Nov; 38(5):100-8. PubMed ID: 5688305 [No Abstract] [Full Text] [Related] [Next] [New Search]